The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fasting mimicking diet reduces anti-OX40/anti PD-L1 and anti-PD-1/anti-CTLA-4 cardiovascular side effects in preclinical melanoma models.
 
Vincenzo Quagliariello
No Relationships to Disclose
 
Salvatore Cortellino
No Relationships to Disclose
 
Gloria Delfanti
No Relationships to Disclose
 
Annabella Di Mauro
No Relationships to Disclose
 
Fabiana Tatangelo
No Relationships to Disclose
 
Vanessa Spagnolo
No Relationships to Disclose
 
Euplio Visco
No Relationships to Disclose
 
Giulia Casorati
No Relationships to Disclose
 
Claudia Chiodoni
No Relationships to Disclose
 
Paolo Della Bona
No Relationships to Disclose
 
Olga Blazevits
No Relationships to Disclose
 
Paolo Antonio Ascierto
Consulting or Advisory Role - 4SC; Anaveon; AstraZeneca; Bayer; Bio-AI Health; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Erasca, Inc; Idera; Immunocore; Italfarmaco; ITeos Therapeutics; Lunaphore Technologies; Medicenna; Merck Serono; Merck Sharp & Dohme; Nektar; Nouscom; Novartis; OncoSec; Pfizer; Philogen; Pierre Fabre; Regeneron; Replimune; Roche/Genentech; Sandoz; Sanofi; Seagen; Sun Pharma; Ultimovacs; ValoTx
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bio-AI Health; MSD Oncology; Pfizer; Pierre Fabre; Replimune
 
Nicola Maurea
No Relationships to Disclose
 
Valter Longo
No Relationships to Disclose